CCL22 and melanoma: Further, analysis of clusters identified within the melanoma patient set comparing patient outcome suggests that suppression of IL-1α, IL-4, IL-5, and CCL22, with concomitant elevation of CXCL10, CCL4, and CCL17, may correlate with more aggressive development of brain metastasis [144].